Drug intelligence / Profile preview

4-Iodobenzo[B]Thiophene-2-Carboxamidine

Development stage: Unknown
Lead developer: Eisai
Modality: Small Molecules

Overview

4-Iodobenzo[B]Thiophene-2-Carboxamidine is an aromatic heterocyclic compound containing the benzo[b]thiophene ring system. It acts as a prothrombin inhibitor and a urokinase-type plasminogen activator inhibitor. The drug is classified as a small molecule and is not approved for use in the U.S. or elsewhere.

Other names: 4-iodobenzo[b]thiophene-2-carboxamidine[amino(4-iodo-1-benzothiophen-2-yl)methylidene]azanium(amino(4-iodo-1-benzothiophen-2-yl)methylidene)azaniumamino(4-iodo-1-benzothiophen-2-yl)methaniminium[amino-(4-iodo-1-benzothiophen-2-yl)methylidene]azaniumBDBM14169BDBM-14169BDBM 14169CA-01CA01CA 01CRA-6860CRA6860CRA 6860DB03136DB-03136DB 03136PD007356PD-007356PD 007356Q27094081Q-27094081Q 27094081

Targets

F2 (Thrombin)PLAU (uPA)

Beyond the preview

Go deeper on 4-Iodobenzo[B]Thiophene-2-Carboxamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-Iodobenzo[B]Thiophene-2-Carboxamidine.

Explore the full profile